Literature DB >> 8673996

Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma.

Y Takebayashi1, S Aklyama, K Yamada, S Akiba, T Aikou.   

Abstract

BACKGROUND: Angiogenesis is reportedly correlated with metastasis, relapse, and prognosis in some types of tumors. Hematogenous or lymph node metastasis and local recurrence are the main elements related to the death of patients with colorectal carcinoma. Thus, the authors examined the microvessel count in colorectal carcinoma to determine how angiogenesis correlates with clinicopathologic factors and prognosis.
METHODS: Paraffin embedded sections from 166 patients with primary colorectal carcinomas that had been completely removed were analyzed for angiogenesis. Vessels were stained with anti-factor VIII polyclonal antibody, and areas with the most discrete microvessels were counted in a 400x field.
RESULTS: Tumor size was significantly correlated with microvessel count. Microvessel counts from patients with lymph node metastasis, lymphatic vessel invasion, venous vessel invasion, or relapse were significantly higher than those without. Furthermore, microvessel count was an independent prognostic factor (P = 0.007), whereas the Dukes stage had more significant prognostic value (P < 0.001) according to the multivariate Cox hazard analysis.
CONCLUSIONS: This study suggested that angiogenesis assessed by the microvessel count was a marker of relapse and prognosis of patients with colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8673996     DOI: 10.1002/(SICI)1097-0142(19960715)78:2<226::AID-CNCR6>3.0.CO;2-J

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  45 in total

Review 1.  Angiogenesis in cancer: the role of endothelin-1.

Authors:  K Dawas; M Loizidou; A Shankar; H Ali; I Taylor
Journal:  Ann R Coll Surg Engl       Date:  1999-09       Impact factor: 1.891

2.  Kip3-ing kinetochores clustered.

Authors:  Ryoma Ohi
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

3.  Isolation and characterization of rat pituitary endothelial cells.

Authors:  Kirti Chaturvedi; Dipak K Sarkar
Journal:  Neuroendocrinology       Date:  2006-10-04       Impact factor: 4.914

4.  Prognostic value of additional pathological variables for long-term survival after curative resection of rectal cancer.

Authors:  Bojan Krebs; Miran Kozelj; Rajko Kavalar; Borut Gajzer; Eldar M Gadzijev
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

5.  The histological growth pattern of colorectal cancer liver metastases has prognostic value.

Authors:  Gert G Van den Eynden; Nigel C Bird; Ali W Majeed; Steven Van Laere; Luc Y Dirix; Peter B Vermeulen
Journal:  Clin Exp Metastasis       Date:  2012-04-03       Impact factor: 5.150

6.  Analysis of colorectal cancer morphology in relation to sex, age, location, and family history.

Authors:  Sam Ghazi; Ulrik Lindforss; Greger Lindberg; Elisabeth Berg; Annika Lindblom; Nikos Papadogiannakis
Journal:  J Gastroenterol       Date:  2012-01-18       Impact factor: 7.527

Review 7.  Exploiting novel molecular targets in gastrointestinal cancers.

Authors:  Wen W Ma; Manuel Hidalgo
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

Review 8.  Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; John Wong
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

9.  Targeted therapies in the management of colorectal carcinoma: role of bevacizumab.

Authors:  Ajithkumar Puthillath; Anush Patel; Marwan G Fakih
Journal:  Onco Targets Ther       Date:  2009-02-18       Impact factor: 4.147

10.  Prognostic value of microvascular density in dukes a and B (t1-t4, n0, m0) colorectal carcinomas.

Authors:  Rafael Uribarrena A; Javier Ortego; Javier Fuentes; Nuria Raventós; Pilar Parra; Rafael Uribarrena E
Journal:  Gastroenterol Res Pract       Date:  2009-11-04       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.